Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × thymoglobulin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myelomonocytic, Juvenile 3 beta-Thalassemia 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Anemia, Refractory, with Excess of Blasts 2 Vasculitis, Central Nervous System 1 Thalassemia 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Rasmussen subacute encephalitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Non-Malignant Neoplasm 1 Neuromyelitis Optica 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myeloid Diseases 1

Interventions

Cyclophosphamide 8 Biopsy 8 pembrolizumab 7 Specimen Handling 7 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Brentuximab Vedotin 6 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 fludarabine phosphate 4 duvelisib 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Etoposide 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡